<!DOCTYPE html><html><head><title>Total hip arthroplasty (THA) and/or total knee arthroplasty (TKA): hospital-level risk-standardized complication rate (RSCR) following elective primary THA and/or TKA.</title><link rel="stylesheet" type="text/css" href="style.css"></head><body><div class='section'>
<h2>General
</h2>
<div class='field field_text'>
<h3>
Title
</h3>
<div class='FieldValue'>
<div class="content_title">Total hip arthroplasty (THA) and/or total knee arthroplasty (TKA): hospital-level risk-standardized complication rate (RSCR) following elective primary THA and/or TKA.</div>
</div>

</div>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Yale New Haven Health Services Corporation (YNHHSC), Center for Outcomes Research and Evaluation (CORE). 2017 procedure-specific measure updates and specifications report: hospital-level risk-standardized complication measure. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2017 Mar. 41 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Measure Domain
</h2>
<div class='field field_picklist-one'>
<h3>
Primary Measure Domain
</h3>
<div class='FieldValue'>
Clinical Quality Measures: Outcome
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Secondary Measure Domain
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>

</div>
<div class='section'>
<h2>Brief Abstract
</h2>
<div class='field field_text'>
<h3>
Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure estimates a hospital-level risk-standardized complication rate (RSCR) following an elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA). The outcome (complication) is defined as any one of the specified complications occurring up to 90 days following the start of the index admission. The hospital that performed the procedure is the one held accountable for the measure outcome (complication or no complication). </p>
<p>The Centers for Medicare &amp; Medicaid Services (CMS) annually reports the measure for individuals who are 65 years and older and are Medicare Fee-for-Service (FFS) beneficiaries hospitalized in non-federal short-term acute care hospitals (including Indian Health Services hospitals) and critical access hospitals.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Rationale
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are commonly performed procedures that improve quality of life. In 2003 there were 202,500 THAs and 402,100 TKAs performed (Kurtz et al., "Projections," 2007) and the number of procedures performed has increased steadily over the past decade (Kurtz et al., "Future," 2007; Ong et al., 2006).</p>
<p>Although these procedures dramatically improve quality of life, they are costly. In 2005 annual hospital charges totaled $3.95 billion and $7.42 billion for primary THA and TKA, respectively (Kurtz et al., "Future," 2007). These costs are projected to increase by 340% to $17.4 billion for THA and by 450% to $40.8 billion for TKA by 2015 (Kurtz et al., "Future," 2007). Medicare is the single largest payer for these procedures, covering approximately two-thirds of all THAs and TKAs performed in the U.S. (Ong et al., 2006). Combined, THA and TKA procedures account for the largest procedural cost in the Medicare budget (Bozic et al., 2008). </p>
<p>Because these are commonly performed and costly procedures, it is imperative to address quality of care. Complications increase costs associated with THA and TKA and affect the quality, and potentially quantity, of life for patients. Although complications following elective THA and TKA are rare, the results can be devastating. Rates for periprosthetic joint infection following THA and TKA range from 1.6% to 2.3%, depending upon the population (Bongartz et al., 2008; Kurtz et al., 2010). Reported 90-day death rates following THA range from 0.7% (Soohoo et al., 2010) to 2.7% (Cram et al., 2007). Rates for pulmonary embolism following TKA range from 0.5% to 0.9% (Cram et al., 2007; Mahomed et al., 2003; Khatod et al., 2008; Solomon et al., 2006). Rates for wound infection in Medicare population-based studies vary between 0.3% and 1.0% (Cram et al., 2007; Mahomed et al., 2003; Solomon et al., 2006). Rates for septicemia range from 0.1%, during the index admission (Browne et al., 2010) to 0.3%, 90 days following discharge for primary TKA (Cram et al., 2007). Rates for bleeding and hematoma following TKA range from 0.94% (Browne et al., 2010) to 1.7% (Huddleston et al., 2009).</p>
<p>Furthermore, hospitals vary in their rate of complications. Analyses in Medicare fee-for-service (FFS) patients (2008 to 2010) demonstrate a median hospital-level risk-standardized complication rate (RSCR) of 3.5% (range 1.8% to 8.9%) after elective primary THA and/or TKA, suggesting room for improvement in clinical care.</p>
<p>The variation in complication rates across hospitals suggests there are considerable differences in the quality of care at the hospital level. Measuring and reporting risk-standardized complications rates will inform health care providers about opportunities to improve care, strengthen incentives for quality improvement, and promote improvements in the quality of care received by patients and the outcomes they experience. The measure will also provide patients with information that could guide their choices regarding where they seek care for these elective procedures. Furthermore, the measure will increase transparency for consumers and has the potential to lower health care costs due to costly readmissions associated with these complications.</p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Rationale
</h3>
<div class='FieldValue'>
<table><tr><td>Bongartz T, Halligan CS, Osmon DR, Reinalda MS, Bamlet WR, Crowson CS, Hanssen AD, Matteson EL. Incidence and risk factors of prosthetic joint infection after total hip or knee  replacement in patients with rheumatoid arthritis. Arthritis Rheum. 2008 Dec 15;59(12):1713-20. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19035425" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Bozic KJ, Rubash HE, Sculco TP, Berry DJ. An analysis of Medicare payment policy for total joint arthroplasty. J Arthroplasty. 2008 Sep;23(6 Suppl 1):133-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18555644" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Browne JA, Cook C, Hofmann AA, Bolognesi MP. Postoperative morbidity and mortality following total knee arthroplasty with computer navigation. Knee. 2010 Mar;17(2):152-6. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19758806" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Cram P, Vaughan-Sarrazin MS, Wolf B, Katz JN, Rosenthal GE. A comparison of total hip and knee replacement in specialty and general hospitals. J Bone Joint Surg Am. 2007 Aug;89(8):1675-84. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17671004" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Huddleston JI, Maloney WJ, Wang Y, Verzier N, Hunt DR, Herndon JH. Adverse events after total knee arthroplasty: a national Medicare study. J Arthroplasty. 2009 Sep;24(6 Suppl):95-100. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19577884" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Khatod M, Inacio M, Paxton EW, Bini SA, Namba RS, Burchette RJ, Fithian DC. Knee replacement: epidemiology, outcomes, and trends in Southern California: 17,080 replacements from 1995 through 2004. Acta Orthop. 2008 Dec;79(6):812-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19085500" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Kurtz S, Ong K, Lau E, Bozic K, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010;468:5.</td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17403800" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Kurtz SM, Ong KL, Schmier J, Mowat F, Saleh K, Dybvik E, Karrholm J, Garellick G, Havelin LI, Furnes O, Malchau H, Lau E. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am. 2007 Oct;89 Suppl 3:144-51. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17908880" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg Am. 2003 Jan;85-A(1):27-32. [28 references] <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12533568" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Ong KL, Mowat FS, Chan N, Lau E, Halpern MT, Kurtz SM. Economic burden of revision hip and knee arthroplasty in Medicare enrollees. Clin Orthop Relat Res. 2006 May;446:22-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16672867" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Solomon DH, Chibnik LB, Losina E, Huang J, Fossel AH, Husni E, Katz JN. Development of a preliminary index that predicts adverse events after total knee  replacement. Arthritis Rheum. 2006 May;54(5):1536-42. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16645987" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Soohoo NF, Farng E, Lieberman JR, Chambers L, Zingmond DS. Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop Relat Res. 2010 Sep;468(9):2363-71. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20428982" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Yale New Haven Health Services Corporation (YNHHSC), Center for Outcomes Research & Evaluation (CORE). Hospital-level risk-standardized complication rate following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKS): measure methodology report. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2012 Jun 25. 90 p.  [23 references]</td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Primary Health Components
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Elective primary total hip arthroplasty (THA); total knee arthroplasty (TKA); complication rate</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The measure cohort consists of admissions for Medicare Fee-for-Service (FFS) beneficiaries aged 65 years and older discharged from non-federal acute care or critical access hospitals, having a qualifying elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) procedure.</p>
<p>The risk-standardized complication rate (RSCR) is calculated as the ratio of the number of "predicted" admissions with a complication to the number of "expected" admissions with a complication at a given hospital, multiplied by the national observed complication rate. For each hospital, the denominator is the number of admissions with a complication expected based on the nation's performance with that hospital's case mix.</p>
<p>See the related "Denominator Inclusions/Exclusions" field.</p>
<p class="Note"><strong>Note</strong>: This outcome measure does not have a traditional numerator and denominator like a core process measure; thus, this field is used to define the measure cohort.</p>
<p class="Note">See the <em>2017 Procedure-specific Complication Measure Updates and Specifications Report</em> for more details.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The outcome for this measure is any complication occurring during the index admission (not coded present on arrival) to 90 days post-date of the index admission.</p>
<p>Complications are counted in the measure only if they occur during the index hospital admission or during a readmission. The measure defines a "complication" as: </p>
<ul style="list-style-type: disc;">
    <li>Acute myocardial infarction (AMI), pneumonia, or sepsis/septicemia/shock during the index admission or a subsequent inpatient admission that occurs within seven days from the start of the index admission; </li>
    <li>Surgical site bleeding or pulmonary embolism during the index admission or a subsequent inpatient admission within 30 days from the start of the index admission; </li>
    <li>Death during the index admission or within 30 days from the start of the index admission; or, </li>
    <li>Mechanical complication or periprosthetic joint infection/wound infection during the index admission or a subsequent inpatient admission that occurs within 90 days from the start of the index admission. </li>
</ul>
<p>The risk-standardized complication rate (RSCR) is calculated as the ratio of the number of "predicted" admissions with a complication to the number of "expected" admissions with a complication at a given hospital, multiplied by the national observed complication rate. For each hospital, the numerator of the ratio is the number of admissions with a complication within 90 days predicted based on the hospital's performance with its observed case mix.</p>
<p>See the related "Numerator Inclusions/Exclusions" field.</p>
<p class="Note"><strong>Note</strong>: This outcome measure does not have a traditional numerator and denominator like a core process measure; thus, this field is used to define the outcome.</p>
<p class="Note">See the <em>2017 Procedure-specific Complication Measure Updates and Specifications Report</em> for more details.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting the Measure
</h2>
<div class='field field_picklist-choice'>
<h3>
Type of Evidence Supporting the Criterion of Quality for the Measure
</h3>
<div class='FieldValue'>
One or more research studies published in a National Library of Medicine (NLM) indexed, peer-reviewed journal
</div>

</div>
<div class='field field_text'>
<h3>
Additional Information Supporting Need for the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>In 2010, there were 168,000 total hip arthroplasties (THAs) and 385,000 total knee arthroplasties (TKAs) performed on Medicare beneficiaries 65 years and older (National Center for Health Statistics [NCHS], 2010). Although these procedures dramatically improve quality of life, they are costly. In 2005, annual hospital charges totaled $3.95 billion and $7.42 billion for primary THA and TKA, respectively (Kurtz et al., 2007). These costs are projected to increase by 340% to 17.4 billion for THA and by 450% to 40.8 billion for TKA by 2015 (Kurtz et al., 2007). Medicare is the single largest payer for these procedures, covering approximately two-thirds of all THAs and TKAs performed in the United States (U.S.) (Ong et al., 2006). Combined, THA and TKA procedures account for the largest procedural cost in the Medicare budget (Bozic et al., 2008). </p>
<p>Since THAs and TKAs are commonly performed and costly procedures, it is imperative to address quality of care. Complications increase costs associated with THA and TKA and affect the quality, and potentially quantity, of life for patients. Although complications following elective THA and TKA are rare, the results can be devastating. Rates for periprosthetic joint infection following THA and TKA range from 1.6% to 2.3%, depending upon the population (Bongartz et al., 2008; Kurtz et al., 2010). Reported 90-day death rates following THA range from 0.7% (Soohoo et al., 2010) to 2.7% (Cram et al., 2007). Rates for pulmonary embolism following TKA range from 0.5% to 0.9% (Cram et al., 2007; Mahomed et al., 2003; Khatod et al., 2008; Solomon et al., 2006). Rates for wound infection in Medicare population-based studies vary between 0.3% and 1.0% (Cram et al., 2007; Mahomed et al., 2003; Solomon et al., 2006). Rates for septicemia range from 0.1%, during the index admission (Browne et al., 2010) to 0.3%, 90 days following discharge for primary TKA (Cram et al., 2007). Rates for bleeding and hematoma following TKA range from 0.94% (Browne et al., 2010) to 1.7% (Huddleston et al., 2009).</p>
<p>The variation in complication rates across hospitals indicates there is room for quality improvement and targeted efforts to reduce these complications could result in better patient care and potential cost savings.</p>
<p>Measurement of patient outcomes allows for a comprehensive view of quality of care that reflects complex aspects of care such as communication between providers and coordinated transitions to the outpatient environment. These aspects are critical to patient outcomes, and are broader than what can be captured by individual process of care measures.</p>
<p>The THA/TKA hospital-specific risk-standardized complication rate (RSCR) measure is thus intended to inform quality-of-care improvement efforts, as individual process-based performance measures cannot encompass all the complex and critical aspects of care within a hospital that contribute to patient outcomes. </p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Additional Information Supporting Need for the Measure
</h3>
<div class='FieldValue'>
<table><tr><td>Bongartz T, Halligan CS, Osmon DR, Reinalda MS, Bamlet WR, Crowson CS, Hanssen AD, Matteson EL. Incidence and risk factors of prosthetic joint infection after total hip or knee  replacement in patients with rheumatoid arthritis. Arthritis Rheum. 2008 Dec 15;59(12):1713-20. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19035425" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Bozic KJ, Rubash HE, Sculco TP, Berry DJ. An analysis of Medicare payment policy for total joint arthroplasty. J Arthroplasty. 2008 Sep;23(6 Suppl 1):133-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18555644" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Browne JA, Cook C, Hofmann AA, Bolognesi MP. Postoperative morbidity and mortality following total knee arthroplasty with computer navigation. Knee. 2010 Mar;17(2):152-6. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19758806" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Cram P, Vaughan-Sarrazin MS, Wolf B, Katz JN, Rosenthal GE. A comparison of total hip and knee replacement in specialty and general hospitals. J Bone Joint Surg Am. 2007 Aug;89(8):1675-84. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17671004" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Huddleston JI, Maloney WJ, Wang Y, Verzier N, Hunt DR, Herndon JH. Adverse events after total knee arthroplasty: a national Medicare study. J Arthroplasty. 2009 Sep;24(6 Suppl):95-100. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19577884" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Khatod M, Inacio M, Paxton EW, Bini SA, Namba RS, Burchette RJ, Fithian DC. Knee replacement: epidemiology, outcomes, and trends in Southern California: 17,080 replacements from 1995 through 2004. Acta Orthop. 2008 Dec;79(6):812-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19085500" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Kurtz S, Ong K, Lau E, Bozic K, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010;468:5.</td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Kurtz SM, Ong KL, Schmier J, Mowat F, Saleh K, Dybvik E, Karrholm J, Garellick G, Havelin LI, Furnes O, Malchau H, Lau E. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am. 2007 Oct;89 Suppl 3:144-51. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17908880" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg Am. 2003 Jan;85-A(1):27-32. [28 references] <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12533568" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>National Center for Health Statistics (NCHS). National Hospital Discharge Survey: number of all-listed procedures for discharges from short-stay hospitals, by procedure category and age: United States, 2010. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2010. 2 p. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Ong KL, Mowat FS, Chan N, Lau E, Halpern MT, Kurtz SM. Economic burden of revision hip and knee arthroplasty in Medicare enrollees. Clin Orthop Relat Res. 2006 May;446:22-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16672867" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Solomon DH, Chibnik LB, Losina E, Huang J, Fossel AH, Husni E, Katz JN. Development of a preliminary index that predicts adverse events after total knee  replacement. Arthritis Rheum. 2006 May;54(5):1536-42. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16645987" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Soohoo NF, Farng E, Lieberman JR, Chambers L, Zingmond DS. Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop Relat Res. 2010 Sep;468(9):2363-71. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20428982" target="_blank">PubMed</a></td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Extent of Measure Testing
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Assessment of Updated Models</strong></p>
<p>The total hip arthroplasty (THA)/total knee arthroplasty (TKA) complication measure estimates hospital-specific risk-standardized complication rates (RSCRs) using a hierarchical logistic regression model. Refer to Section 2 in the original measure documentation for a summary of the measure methodology and model risk-adjustment variables. Refer to prior methodology and technical reports for further details.</p>
<p>The Centers for Medicare &amp; Medicaid Services (CMS) evaluated and validated the performance of the model, using April 2013 to March 2016 data for the 2017 reporting period. They also evaluated the stability of the risk-adjustment model over the three-year measurement period by examining the model variable frequencies, model coefficients, and the performance of the risk-adjustment model in each year. </p>
<p>CMS assessed logistic regression model performance in terms of discriminant ability for each year of data and for the three-year combined period. They computed two summary statistics for assessing model performance: the predictive ability and the area under the receiver operating characteristic (ROC) curve (c-statistic). CMS also computed between-hospital variance for each year of data and for the three-year combined period. If there were no systematic differences between hospitals, the between-hospital variance would be zero. </p>
<p>The results of these analyses for the measure are presented in Section 4.2 of the original measure documentation.</p>
<p><strong>THA/TKA Complication 2017 Model Results</strong></p>
<p><em>Frequency of THA/TKA Model Variables </em></p>
<p>CMS examined the change in the frequencies of clinical and demographic variables. Frequencies of model variables were stable over the measurement period. There were no large changes (greater than 2% absolute change) in the frequencies. However, the increases in frequencies of Morbid obesity and Renal failure observed in 2016 public reporting continue, but only by 0.8% and 1.1%, respectively, over the three-year period. </p>
<p><em>THA/TKA Model Parameters and Performance </em></p>
<p>Table 4.2.2 in the original measure documentation shows hierarchical logistic regression model variable coefficients by individual year and for the combined three-year dataset. Table 4.2.3 in the original measure documentation shows the risk-adjusted odds ratios (ORs) and 95% confidence intervals for the THA/TKA complication model by individual year and for the combined three-year dataset. Overall, the variable effect sizes were relatively constant across years. In addition, model performance was stable over the three-year time period; the c-statistic remained constant at 0.65.</p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Extent of Measure Testing
</h3>
<div class='FieldValue'>
<table><tr><td>Yale New Haven Health Services Corporation (YNHHSC), Center for Outcomes Research and Evaluation (CORE). 2017 procedure-specific measure updates and specifications report: hospital-level risk-standardized complication measure. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2017 Mar. 41 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>State of Use of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
State of Use
</h3>
<div class='FieldValue'>
Current routine use
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Current Use
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Application of the Measure in its Current Use
</h2>
<div class='field field_picklist-choice'>
<h3>
Measurement Setting
</h3>
<div class='FieldValue'>
Hospital Inpatient
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Professionals Involved in Delivery of Health Services
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Least Aggregated Level of Services Delivery Addressed
</h3>
<div class='FieldValue'>
Single Health Care Delivery or Public Health Organizations
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Statement of Acceptable Minimum Sample Size
</h3>
<div class='FieldValue'>
Specified
</div>

</div>
<div class='field field_text'>
<h3>
Target Population Age
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Age greater than or equal to 65 years</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Target Population Gender
</h3>
<div class='FieldValue'>
Either male or female
</div>

</div>

</div>
<div class='section'>
<h2>National Strategy for Quality Improvement in Health Care
</h2>
<div class='field field_text'>
<h3>
National Quality Strategy Aim
</h3>
<div class='FieldValue'>
<ul><li>Better Care</li></ul>
</div>

</div>
<div class='field field_text'>
<h3>
National Quality Strategy Priority
</h3>
<div class='FieldValue'>
<ul><li>Making Care Safer</li><li>Prevention and Treatment of Leading Causes of Mortality</li></ul>
</div>

</div>

</div>
<div class='section'>
<h2>Institute of Medicine (IOM) National Health Care Quality Report Categories
</h2>
<div class='field field_picklist-choice'>
<h3>
IOM Care Need
</h3>
<div class='FieldValue'>
Getting Better
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
IOM Domain
</h3>
<div class='FieldValue'>
Effectiveness
</div>
<div class='FieldValue'>
Safety
</div>

</div>

</div>
<div class='section'>
<h2>Data Collection for the Measure
</h2>
<div class='field field_text'>
<h3>
Case Finding Period
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Discharges April 1, 2013 through March 31, 2016</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Denominator Sampling Frame
</h3>
<div class='FieldValue'>
Patients associated with provider
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Denominator (Index) Event or Characteristic
</h3>
<div class='FieldValue'>
Institutionalization
</div>
<div class='FieldValue'>
Patient/Individual (Consumer) Characteristic
</div>
<div class='FieldValue'>
Therapeutic Intervention
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Denominator Time Window
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
An <em>index admission </em>is the hospitalization to which the complication outcome is attributed and includes admissions for patients: </p>
<ul style="list-style-type: disc;">
    <li>Having a qualifying elective primary total hip arthroplasty (THA)/total knee arthroplasty (TKA)procedure* during the index admission; </li>
    <li>Enrolled in Medicare Fee-for-Service (FFS) Part A and Part B for the 12 months prior to the date of admission, and enrolled in Part A during the index admission; and, </li>
    <li>Aged 65 or over. </li>
</ul>
<p><em>Elective primary THA/TKA procedures</em> are defined as those THA/TKA procedures without any of the following: </p>
<ul style="list-style-type: disc;">
    <li>Fracture of the pelvis or lower limbs coded in the principal or secondary discharge diagnosis fields of the index admission; </li>
    <li>A concurrent partial hip arthroplasty; </li>
    <li>A concurrent revision, resurfacing, or implanted device/prosthesis removal procedure; </li>
    <li>Mechanical complication coded in the principal discharge diagnosis field of the index admission; </li>
    <li>Malignant neoplasm of the pelvis, sacrum, coccyx, lower limbs, or bone/bone marrow or a disseminated malignant neoplasm coded in the principal discharge diagnosis field; or, </li>
    <li>Transfer from another acute care facility for the THA/TKA. (<strong>Note</strong>: The THA/TKA complication measure excludes index admissions for patients who are transferred in to the index hospital from another hospital, as these admissions likely do not represent elective THA/TKA procedures.)</li>
</ul>
<p class="Note">*International Classification of Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS) codes used to define a THA/TKA procedure in claims for discharges on or after October 1, 2015 are listed in the original measure documentation. International Classification of Diseases, Ninth Revision (ICD-9) code lists for discharges prior to October 1, 2015 can be found in the <em><a href="https://www.qualitynet.org/dcs/ContentServer?cid=1228774719413&amp;pagename=QnetPublic%2FPage%2FQnetTier4&amp;c=Page" title="QualityNet Web site">2016 Procedure-Specific Measure Updates and Specifications Report Hospital-Level Risk-Standardized Complication Measure: Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) &ndash; Version 5.0</a></em>.</p>
<p><strong>Exclusions</strong><br />
The THA/TKA complication measure excludes index admissions for patients: </p>
<ul style="list-style-type: disc;">
    <li>Without at least 90 days post-discharge enrollment in Medicare FFS; </li>
    <li>Discharged against medical advice; or, </li>
    <li>With more than two THA/TKA procedure codes during the index admission. </li>
</ul>
<p>For patients with more than one eligible admission for a THA/TKA procedure in a given year, only one index admission is randomly selected for inclusion in the cohort. Additional admissions within that year are excluded.</p></div>
</div>

</div>
<div class='field field_picklist-choice-4'>
<h3>
Exclusions/Exceptions
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
The outcome for this measure is any complication occurring during the index admission (not coded present on arrival) to 90 days post-date of the index admission.</p>
<p>Complications are counted in the measure only if they occur during the index hospital admission or during a readmission. The measure defines a "complication" as: </p>
<ul style="list-style-type: disc;">
    <li>Acute myocardial infarction (AMI), pneumonia, or sepsis/septicemia/shock during the index admission or a subsequent inpatient admission that occurs within seven days from the start of the index admission; </li>
    <li>Surgical site bleeding or pulmonary embolism during the index admission or a subsequent inpatient admission within 30 days from the start of the index admission; </li>
    <li>Death during the index admission or within 30 days from the start of the index admission; or, </li>
    <li>Mechanical complication or periprosthetic joint infection/wound infection during the index admission or a subsequent inpatient admission that occurs within 90 days from the start of the index admission. </li>
</ul>
<p>The risk-standardized complication rate (RSCR) is calculated as the ratio of the number of "predicted" admissions with a complication to the number of "expected" admissions with a complication at a given hospital, multiplied by the national observed complication rate. For each hospital, the numerator of the ratio is the number of admissions with a complication within 90 days predicted based on the hospital's performance with its observed case mix.</p>
<p class="Note"><strong>Note</strong>: This outcome measure does not have a traditional numerator and denominator like a core process measure; thus, this field is used to define the outcome. </p>
<p class="Note">The outcome for this measure is any one of the specified complications occurring during the index admission or during a readmission except for deaths, which can occur anywhere as long as it is within 30 days of the start of the index admission. The measure assesses a dichotomous yes or no outcome of whether each admitted patient experiences one or more of the complications defined above. Therefore, if a patient experiences one or more complications in the applicable time period, the outcome variable is coded as a "yes." </p>
<p class="Note">See the <em><a href="https://www.qualitynet.org/dcs/ContentServer?c=Page&amp;pagename=QnetPublic%2FPage%2FQnetTier4&amp;cid=1228772782693" title="QualityNet Web site">2017 Procedure-Specific Measure Updates and Specifications Report Hospital-Level Risk-Standardized Complication Measure: Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) &ndash; Version 6.0</a></em> for more details.</p>
<p><strong>Exclusions</strong><br />
The measure captures all complications occurring during the index admission, regardless of when they occur, with the exception of complications that are coded as present on admission (POA).</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Numerator Search Strategy
</h3>
<div class='FieldValue'>
Institutionalization
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Data Source
</h3>
<div class='FieldValue'>
Administrative clinical data
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Type of Health State
</h3>
<div class='FieldValue'>
Adverse Health State
</div>

</div>
<div class='field field_text'>
<h3>
Instruments Used and/or Associated with the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>None</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Computation of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
Measure Specifies Disaggregation
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Scoring
</h3>
<div class='FieldValue'>
Rate/Proportion
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Interpretation of Score
</h3>
<div class='FieldValue'>
Desired value is a lower score
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Allowance for Patient or Population Factors
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Description of Allowance for Patient or Population Factors
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Risk-Adjustment Variables </strong></p>
<p>In order to account for differences in case mix among hospitals, the measure adjusts for variables (for example, age, comorbid diseases, and indicators of patient frailty) that are clinically relevant and have relationships with the outcome. For each patient, risk-adjustment variables are obtained from inpatient, outpatient, and physician Medicare administrative claims data extending 12 months prior to, and including, the index admission. </p>
<p>The measure adjusts for case mix differences among hospitals based on the clinical status of the patient at the time of the index admission. Accordingly, only comorbidities that convey information about the patient at that time or in the 12 months prior, and not complications that arise during the course of the hospitalization, are included in the risk adjustment. </p>
<p>The measure does not adjust for socioeconomic status (SES) because the association between SES and health outcomes can be due, in part, to differences in the quality of health care that groups of patients with varying SES receive. The intent is for the measure to adjust for patient demographic and clinical characteristics while illuminating important quality differences. As part of the National Quality Forum's (NQF's) endorsement process for this measure, the Centers for Medicare &amp; Medicaid Services (CMS) completed analyses for the two-year Sociodemographic Trial Period. Although univariate analyses found that the patient-level observed (unadjusted) complication rate is higher for dual-eligible patients (for patients living in lower Agency for Healthcare Research and Quality [AHRQ] SES Index census block groups) and African-American patients compared with all other patients, analyses in the context of a multivariable model demonstrated that the effect size of these variables was small, and that the c-statistics for the model are similar with and without the addition of these variables. </p>
<p>Refer to Appendix D in the original measure documentation for the list of comorbidity risk-adjustment variables and the list of complications that are excluded from risk adjustment if they only occur during the index admission. </p></div>
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Standard of Comparison
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Identifying Information
</h2>
<div class='field field_text'>
<h3>
Original Title
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Hospital-level RSCR following elective primary THA and/or TKA.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Collection Name
</h3>
<div class='FieldValue'>
National Hospital Inpatient Quality Measures
</div>

</div>
<div class='field field_text'>
<h3>
Measure Set Name
</h3>
<div class='FieldValue'>
Complication Measure
</div>

</div>
<div class='field field_orglist'>
<h3>
Submitter
</h3>
<div class='FieldValue'>
Centers for Medicare & Medicaid Services - Federal Government Agency [U.S.]
</div>

</div>
<div class='field field_orglist-p'>
<h3>
Developer
</h3>
<div class='FieldValue'>
Centers for Medicare & Medicaid Services - Federal Government Agency [U.S.]
</div>
<div class='FieldValue'>
Yale-New Haven Health Services Corporation/Center for Outcomes Research and Evaluation under contract to Centers for Medicare & Medicaid Services - Academic Affiliated Research Institute
</div>

</div>
<div class='field field_text'>
<h3>
Funding Source(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Centers for Medicare &amp; Medicaid Services (CMS)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Composition of the Group that Developed the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure was developed by a team of experts: </p>
<ul style="list-style-type: disc;">
    <li>Laura M. Grosso, PhD, MPH, Yale New Haven Health Services Corporation/Center for Outcomes Research &amp; Evaluation (YNHHSC/CORE) </li>
    <li>Jeptha P. Curtis, MD, YNHHSC/CORE </li>
    <li>Zhenqiu Lin, PhD, YNHHSC/CORE </li>
    <li>Lori L. Geary, MPH, YNHHSC/CORE </li>
    <li>Smitha Vellanky, MSc, YNHHSC/CORE </li>
    <li>Craig Parzynski, MS, YNHHSC/CORE </li>
    <li>Lesli S. Ott, MA, MA, YNHHSC/CORE </li>
    <li>Susannah M. Bernheim, MD, MHS, YNHHSC/CORE </li>
    <li>Carol Oladele, PhD, Yale School of Medicine </li>
    <li>Yongfei Wang, MS, Yale School of Medicine </li>
    <li>Elizabeth E. Drye, MD, SM, Yale School of Medicine </li>
    <li>Harlan M. Krumholz, MD, SM, Yale School of Medicine </li>
    <li>Daniel J. Berry, MD, Mayo Clinic College of Medicine </li>
    <li>Kevin J. Bozic, MD, MBA, University of California, San Francisco </li>
    <li>Robert Bucholz, MD, University of Texas Southwestern Medical Center </li>
    <li>Lisa Gale Suter, MD, Yale School of Medicine </li>
    <li>Charles M. Turkelson, PhD, American Association of Orthopaedic Surgeons </li>
    <li>Lawrence Weis, MD, Yale School of Medicine </li>
    <li>Mark L. Francis, MD, Texas Tech University Health Sciences Center </li>
    <li>Cynthia Jacelon, PhD, RN, CRRN, University of Massachusetts </li>
    <li>Norman Johanson, MD, Drexel University College of Medicine </li>
    <li>C. Kent Kwoh, MD, University of Pittsburgh </li>
    <li>Courtland G. Lewis, MD, American Association of Orthopaedic Surgeons </li>
    <li>Jay Lieberman, MD, University of Connecticut Health Center </li>
    <li>Peter Lindenauer, MD, MSc, Baystate Medical Center </li>
    <li>Russell Robbins, MD, MBA, Mercer's Total Health Management </li>
    <li>Barbara Schaffer, THA Patient </li>
    <li>Nelson SooHoo, MD, MPH, University of California at Los Angeles </li>
    <li>Steven H. Stern, MD, United Healthcare </li>
    <li>Richard E. White, Jr., MD, American Association of Hip and Knee Surgeons </li>
    <li>Kanchana R. Bhat, MPH, YNHHSC/CORE </li>
    <li>Sharon-Lise T. Normand, PhD, Harvard Medical School, Department of Health Care Policy </li>
    <li>Angela Merrill, PhD, Mathematica Policy Research </li>
    <li>Eric M. Schone, PhD, Mathematica Policy Research </li>
    <li>Sandi Nelson, MPP, Mathematica Policy Research </li>
    <li>Marian Wrobel, PhD, Mathematica Policy Research </li>
    <li>Lein Han, PhD, CMS </li>
    <li>Michael Rapp, MD, CMS </li>
</ul></div>
</div>

</div>
<div class='field field_text'>
<h3>
Financial Disclosures/Other Potential Conflicts of Interest
</h3>
<div class='FieldValue'>
<div class="content_para"><p>None</p></div>
</div>

</div>
<div class='field field_orglist'>
<h3>
Endorser
</h3>
<div class='FieldValue'>
National Quality Forum - None
</div>

</div>
<div class='field field_plain-text'>
<h3>
NQF Number
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Date of Endorsement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>2017 Jan 25</p></div>
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Core Quality Measures
</h3>
<div class='FieldValue'>
Orthopedics
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Measure Initiative(s)
</h3>
<div class='FieldValue'>
Hospital Compare
</div>
<div class='FieldValue'>
Hospital Inpatient Quality Reporting Program
</div>

</div>
<div class='field field_text'>
<h3>
Adaptation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure was not adapted from another source.</p></div>
</div>

</div>
<div class='field field_date'>
<h3>
Date of Most Current Version in NQMC
</h3>
<div class='FieldValue'>
2017 Mar
</div>

</div>
<div class='field field_text'>
<h3>
Measure Maintenance
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Annual</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Date of Next Anticipated Revision
</h3>
<div class='FieldValue'>
<div class="content_para"><p>2018 Apr</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the measure.</p>
<p>This measure updates a previous version: Specifications manual for national hospital inpatient quality measures, version 5.0b. Centers for Medicare &amp; Medicaid Services (CMS), The Joint Commission; Effective 2015 Oct 1. various p. </p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Availability
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Source available from the <a href="https://www.qualitynet.org/dcs/ContentServer?c=Page&amp;pagename=QnetPublic%2FPage%2FQnetTier4&amp;cid=1228772782693" title="QualityNet Web site">QualityNet Web site</a>. </p>
<p>Check the QualityNet Web site regularly for the most recent version of the specifications manual and for the applicable dates of discharge.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Companion Documents
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The following are available:</p>
<ul style="list-style-type: disc;">
    <li>Hospital compare: a quality tool provided by Medicare. [internet]. Washington (DC): U.S. Department of Health and Human Services; [accessed 2015 May 27]. This is available from the <a href="http://www.medicare.gov/hospitalcompare/search.html" title="Medicare Web site" target="_blank">Medicare Web site</a>. </li>
    <li>Yale New Haven Health Services Corporation (YNHHSC), Center for Outcomes Research and Evaluation (CORE). Medicare hospital quality chartbook: performance report on outcome measures. Baltimore (MD): Centers for Medicare &amp; Medicaid Services (CMS); 2016 Sep. Available from the <a href="https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/OutcomeMeasures.html" title="CMS Web site" target="_blank">CMS Web site</a>. </li>
    <li>Yale New Haven Health Services Corporation (YNHHSC), Center for Outcomes Research and Evaluation (CORE). 2017 procedure-specific complication measure updates and specifications report: supplemental ICD-10 code lists for use with claims for discharges on or after October 1, 2015. Baltimore (MD): Centers for Medicare &amp; Medicaid Services (CMS); 2017. Available from the <a href="https://www.qualitynet.org/dcs/ContentServer?c=Page&amp;pagename=QnetPublic%2FPage%2FQnetTier4&amp;cid=1228772782693" title="QualityNet Web site">QualityNet Web site</a>. </li>
</ul></div>
</div>

</div>
<div class='field field_text'>
<h3>
NQMC Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NQMC summary was completed by ECRI Institute on December 4, 2013. The information was verified by the measure developer on January 10, 2014.</p>
<p>This NQMC summary was updated by ECRI Institute on December 4, 2014. The information was verified by the measure developer on January 21, 2015.</p>
<p>This NQMC summary was updated by ECRI Institute on August 7, 2015. The information was verified by the measure developer on September 23, 2015.</p>
<p>This NQMC summary was updated again by ECRI Institute on November 8, 2017. information was verified by the measure developer on December 12, 2017.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Copyright Statement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>No copyright restrictions apply.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Production
</h2>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Yale New Haven Health Services Corporation (YNHHSC), Center for Outcomes Research and Evaluation (CORE). 2017 procedure-specific measure updates and specifications report: hospital-level risk-standardized complication measure. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2017 Mar. 41 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Disclaimer
</h2>
<div class='field field_text'>
<h3>
NQMC Disclaimer
</h3>
<div class='FieldValue'>
<p>The National Quality Measures Clearinghouse (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p>
</div>

</div>

</div>
</body></html>